On July 28, Aimed Alliance sent a letter to the Centers for Consumer Information and Insurance Oversight (CCIIO) and the…
Prior to the Maryland Prescription Drug Affordability Board’s July meeting to conduct cost affordability reviews for Farxiga and Jardiance, Aimed…
On July 4, 2025, President Trump signed the One Big Beautiful Bill Act into law, notably without a controversial provision…
Washington, D.C. — June 30, 2025 — The not-for-profit Aimed Alliance, released a comprehensive new report analyzing how state policies…
On June 5, 2025, Aimed Alliance hosted a one-hour webinar to introduce health care access advocates to the judicial system…
The Inflation Reduction Act (IRA) aimed to lower prescription drug costs by capping annual out-of-pocket spending for Medicare beneficiaries at…
On June 12, Nevada Governor Joe Lombardo vetoed Assembly Bill 259, legislation that would have imposed Medicare’s maximum fair price…
The Trump administration has paused enforcement of the 2008 Mental Health Parity and Addiction Equity Act, which requires insurers to…
In a recent JAMA article, the FDA outlined its priorities to address delays in the drug approval process, including the…
Aimed Alliance sent a letter to Governor Lombardo opposing Nevada Assembly Bill 259, which would cap health plan reimbursement for…